Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Sales (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Return on Sales for 17 consecutive years, with 0.01% as the latest value for Q1 2026.

  • Quarterly Return on Sales fell 3.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01% through Jan 2026, down 4.0% year-over-year, with the annual reading at 0.01% for FY2026, 4.0% down from the prior year.
  • Return on Sales for Q1 2026 was 0.01% at Usana Health Sciences, up from 0.03% in the prior quarter.
  • The five-year high for Return on Sales was 0.1% in Q4 2022, with the low at 0.03% in Q3 2025.
  • Average Return on Sales over 5 years is 0.05%, with a median of 0.05% recorded in 2023.
  • Peak annual rise in Return on Sales hit 13bps in 2022, while the deepest fall reached -13bps in 2022.
  • Over 5 years, Return on Sales stood at 0.1% in 2022, then decreased by -24bps to 0.08% in 2023, then crashed by -72bps to 0.02% in 2024, then tumbled by -249bps to 0.03% in 2025, then surged by 77bps to 0.01% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.01%, 0.03%, and 0.04% for Q1 2026, Q3 2025, and Q2 2025 respectively.